Prevalence and Predictors of Virological Failure Among Adults Living with HIV in South Wollo Zone, Northeast Ethiopia: A Retrospective Cohort Study

References

• Global AIDS update; 2018 https://www.unaids.org/en/resources/fact-sheet. Accessed 819, 2020.
   Google Scholar
• Global AIDS Response Progress Reporting (GARPR) 2016. UNAIDS 2016 estimates.
   Google Scholar
• Ethiopia HIV/AIDS Progress in 2014 WHO update March 2015.
   Google Scholar
• Marconi VC, Grandits GA, Weintrob AC, et al. Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV natural history study. AIDS Res Ther. 2010;7(1):14. doi:10.1186/1742-6405-7-1420507622
   PubMedGoogle Scholar
• Vaamonde CM, Hoover DR, Anastos K, et al. Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women. AIDS Res Hum Retroviruses. 2006;22(3):222–231. doi:10.1089/aid.2006.22.22216545008
   PubMedGoogle Scholar
• Palombi L, Marazzi MC, Guidotti G, et al. Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral treated patients in Sub-Saharan African sites with comprehensive monitoring availability. Clin Infect Dis. 2009;48:115–122. doi:10.1086/59331220380075
   PubMedGoogle Scholar
• Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, Freedberg KA. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007;44(1):30–37. doi:10.1097/01.qai.0000248351.10383.b717106280
   PubMed Web of Science ®Google Scholar
• Palladino C, Briz V, Bellon JM, et al. Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique. PLoS One. 2013;8(12):e82718. doi:10.1371/journal.pone.008271824376569
   PubMedGoogle Scholar
• Ayalew MB, Kumilachew D, Belay A, et al. First-line antiretroviral treatment failure and associated factors in HIV patients at the University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia. HIV/AIDS (Auckland, Nz). 2016;8:141–146.
   PubMedGoogle Scholar
• Ayele G, Tessema B, Amsalu A, Ferede G, Yismaw G. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia. BMC Immunol. 2018;19(1):37. doi:10.1186/s12865-018-0278-430558580
   PubMedGoogle Scholar
• Kan W, Teng T, Liang S, et al. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study. BMJ Open. 2017;7(9):e016012. doi:10.1136/bmjopen-2017-016012
   PubMed Web of Science ®Google Scholar
• Gross R, Yip B, Lo Re V, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194(8):1108–1114. doi:10.1086/50768016991085
   PubMed Web of Science ®Google Scholar
• Huong DT, Bannister W, Phong PT, Kirk O, Peters L. Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam. Int J STD AIDS. 2011;22(11):659–664. doi:10.1258/ijsa.2011.01051522096052
   PubMedGoogle Scholar
• Organization WH. Global action plan on HIV drug resistance 2017–2021. 2017.
   Google Scholar
• Grabar S, Pradier C, Corfec EL, et al. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS (London, England). 2000;14(2):141–149. doi:10.1097/00002030-200001280-00009
   PubMed Web of Science ®Google Scholar
• Hare AQ, Ordóñez CE, Johnson BA, et al. Gender-specific risk factors for virologic failure in KwaZuluNatal: automobile ownership and financial insecurity. AIDS Behav. 2014;18(11):2219–2229. doi:10.1007/s10461-014-0849-125037488
   PubMedGoogle Scholar
• Thorsteinsson K, Ladelund S, Jensen-Fangel S, et al. Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study. BMC Infect Dis. 2012;12(1):1–11. doi:10.1186/1471-2334-12-29322214291
   PubMedGoogle Scholar
• Teshome W, Assefa A, He W. Predictors of immunological failure of antiretroviral therapy among HIV infected patients in Ethiopia: a matched case-control study. PLoS One. 2014;9(12):e115125. doi:10.1371/journal.pone.011512525536416
   PubMedGoogle Scholar
• Ding H, Wilson CM, Modjarrad K, McGwin G, Tang J, Vermund SH. Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus infected adolescents. Arch Pediatr Adolesc Med. 2009;163(12):1100–1105. doi:10.1001/archpediatrics.2009.20419996046
   PubMed Web of Science ®Google Scholar
• Nanzigu S, Kiguba R, Kabanda J, et al. Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans. HIV/AIDS (Auckland, Nz). 2013;5:309–319.
   PubMedGoogle Scholar
• Kokeb M, Degu G. Immunological response of HIV-infected children to highly active antiretoviral therapy at Gondar University Hospital, North-Western Ethiopia. Ethiop J Health Sci. 2016;26(1):25–30. doi:10.4314/ejhs.v26i1.626949313
   PubMedGoogle Scholar
• Petersen ML, Tran L, Geng EH, et al. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS (London, England). 2014;28(14):2097–2107. doi:10.1097/QAD.0000000000000349
   PubMed Web of Science ®Google Scholar
• Bacha T, Tilahun B, Worku A. Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy. BMC Infect Dis. 2012;12:197. doi:10.1186/1471-2334-12-19722916836
   PubMed Web of Science ®Google Scholar
• Yirdaw KD, Hattingh S, Paraskevis D. Prevalence and predictors of immunological failure among HIV patients on HAART in Southern Ethiopia. PLoS One. 2015;10(5):e0125826. doi:10.1371/journal.pone.012582625961732
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: 2013 WHO Recommendations for a Public Health Approach. World Health Organization; 2016.
   Google Scholar
• Teshome W, Tefera A. Detection of immunological treatment failure among HIV infected patients in Ethiopia: a retrospective cohort study. BMC Immunol. 2015;16(1):1–7. doi:10.1186/s12865-015-0120-125636521
   PubMedGoogle Scholar
• Vanobberghen FM, Kilama B, Wringe A, et al. Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data. Trop Med Int Health. 2015;20(7):880–892. doi:10.1111/tmi.1250725779383
   PubMed Web of Science ®Google Scholar
• Bunupuradah T, Puthanakit T, Kosalaraksa P, et al. Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children. AIDS Res Ther. 2011;8(1):1–6. doi:10.1186/1742-6405-8-4021226969
   PubMedGoogle Scholar
• Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Rie AV. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc. 2009;12:38. doi:10.1186/1758-2652-12-3820017918
   PubMedGoogle Scholar
• Tsuchiya N, Pathipvanich P, Wichukchinda N, et al. Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort study. BMC Infect Dis. 2014;14:565. doi:10.1186/s12879-014-0565-525361850
   PubMedGoogle Scholar
• Organization WH. HIV Drug Resistance Report 2019. 2019.
   Google Scholar
• Dejene TA, Tegegne AS, Ndlovu P, Zewotir T. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia. PLoS One. 2018;18(1):197.
   Google Scholar
• Teshome Yimer Y, Yalew AW, Cameron DW. Magnitude and predictors of anti-retroviral treatment (ART) failure in private health facilities in Addis Ababa, Ethiopia. PLoS One. 2015;10(5):e0126026. doi:10.1371/journal.pone.012602625946065
   PubMed Web of Science ®Google Scholar
• Bulage L. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. Pharmacol Res Perspect. 2017;17(1):326.
   Google Scholar
• Shet A, Neogi U, Kumarasamy N, DeCosta A, Shastri S, Rewari BB. Virological efficacy with first-line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression. Trop Med Int Health. 2015;20(11):1462–1472. doi:10.1111/tmi.1256326146863
   PubMedGoogle Scholar
• Gesesew HA, Ward P, Woldemichael K, Mwanri L. Immunological failure in HIV-infected adults from 2003 to 2015 in Southwest Ethiopia: a retrospective cohort study. PLoS One. 2018;8(8):e017413.
   Google Scholar
• Lenjiso GA, Endale BS, Bacha YD. Clinical and immunological failure among HIV-positive adults taking first-line antiretroviral therapy in Dire Dawa, eastern Ethiopia. BMC Public Health. 2019;19(1):771. doi:10.1186/s12889-019-7078-531208459
   PubMedGoogle Scholar
• Dragsted UB, Mocroft A, Vella S, et al. Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study. J Infect Dis. 2004;190(1):148–155. doi:10.1086/42078615195254
   PubMedGoogle Scholar
• Musa BM, Coker M, Bussell S, et al. Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria. Ann Saudi Med. 2015;35(4):303–311. doi:10.5144/0256-4947.2015.30326497711
   PubMedGoogle Scholar
• Alave J, Paz J, Gonzalez E, et al. [Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru]. Rev Chilena Infectol. 2013;30(1):42–48. doi:10.4067/S0716-1018201300010000623450408
   PubMedGoogle Scholar
• Haile D, Takele A, Gashaw K, Demelash H, Nigatu D, Ho W. Predictors of treatment failure among adult antiretroviral treatment (ART) clients in Bale Zone Hospitals, South Eastern Ethiopia. PLoS One. 2016;11(10):e0164299. doi:10.1371/journal.pone.016429927716827
   PubMed Web of Science ®Google Scholar
• Telele NF, Kalu AW, Marrone G, et al. Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PLoS One. 2018;13(7):e0200505. doi:10.1371/journal.pone.020050529995957
   PubMed Web of Science ®Google Scholar
• Ferreyra C, Yun O, Eisenberg N, et al. Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya. PLoS One. 2012;7(11):e49834. doi:10.1371/journal.pone.004983423185450
   PubMed Web of Science ®Google Scholar
• Rajasekarana S, Jeyaseelanb L, Vijilaa S, Gomathia C, Raja K. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience. AIDS (London, England). 2007;21(suppl 4):S47–S53. doi:10.1097/01.aids.0000279706.24428.78
   PubMed Web of Science ®Google Scholar
• Tran DA, Wilson DP, Shakeshaft A, Ngo AD, Doran C, Zhang L. Determinants of virological failure after 1 year’s antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces. Sex Transm Infect. 2014;90(7):538–544. doi:10.1136/sextrans-2013-05135324619575
   PubMedGoogle Scholar
• Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T, Teshome DF. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV/AIDS (Auckland, Nz). 2017;9:153–159.
   PubMedGoogle Scholar
• Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis. 2019;19(1):305. doi:10.1186/s12879-019-3924-430943903
   PubMedGoogle Scholar
• Sadashiv MS, Rupali P, Manesh A, et al. Risk factors of clinical and immunological failure in South Indian cohort on generic antiretroviral therapy. J Assoc Physicians India. 2017;65(12):34–39.
   PubMedGoogle Scholar